Inventor
SCHAER DAVID
US27 patents
Patents
27 patentsUS10280226B2May 7, 2019
Anti-GITR antibodies and methods of use thereof
AGENUS INC17 citations93
US10259882B2Apr 16, 2019
Anti-OX40 antibodies
AGENUS INC16 citations93
US10155818B2Dec 18, 2018
Anti-GITR antibodies and methods of use thereof
AGENUS INC17 citations93
US10144779B2Dec 4, 2018
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC12 citations92
US11638755B2May 2, 2023
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC4 citations84
US10836830B2Nov 17, 2020
Antibodies and methods of use thereof
AGENUS INC12 citations84
US10479833B2Nov 19, 2019
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC8 citations84
US10323091B2Jun 18, 2019
Anti-PD-1 antibodies and methods of use thereof
AGENUS INC5 citations83
US11013802B2May 25, 2021
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC5 citations82
US10912831B1Feb 9, 2021
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC6 citations82
US10626181B2Apr 21, 2020
Nucleic acids encoding anti-OX40 antibodies
AGENUS INC7 citations82
US10577426B2Mar 3, 2020
Anti-GITR antibodies and methods of use thereof
AGENUS INC3 citations82
US11267889B2Mar 8, 2022
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC2 citations73
US11345755B2May 31, 2022
Anti-PD-1 antibodies and methods of use thereof
AGENUS INC2 citations72
US11332536B2May 17, 2022
Vectors comprising nucleic acids encoding anti-OX40 antibodies
AGENUS INC1 citations72
US10829559B2Nov 10, 2020
Anti-GITR antibodies and methods of use thereof
AGENUS INC1 citations72
US11993653B2May 28, 2024
Antibodies and methods of use thereof
AGENUS INC2 citations71
US11472883B2Oct 18, 2022
Methods of administering anti-OX40 antibodies
AGENUS INC1 citations71
US11447557B2Sep 20, 2022
Antibodies and methods of use thereof
AGENUS INC3 citations71
US11136404B2Oct 5, 2021
Anti-OX40 antibodies
AGENUS INC1 citations71
US10800849B2Oct 13, 2020
Anti-GITR antibodies and methods of use thereof
AGENUS INC2 citations71
US12492257B2Dec 9, 2025
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC0 citations62
US11897962B2Feb 13, 2024
Anti-GITR antibodies and methods of use thereof
AGENUS INC0 citations62
US12246066B2Mar 11, 2025
Anti-CTLA-4 antibodies and methods of use thereof
AGENUS INC0 citations61
US11401335B2Aug 2, 2022
Anti-GITR antibodies and methods of use thereof
AGENUS INC0 citations61
US11359028B2Jun 14, 2022
Anti-OX40 antibodies and anti-GITR antibodies
AGENUS INC1 citations61
US10450373B2Oct 22, 2019
Anti-PD-1 antibodies and methods of use thereof
AGENUS INC0 citations51